Valuation
- Market cap
- 2,000
- Revenue TTM
- $25,400,000
- Net income TTM
- $17,930,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 70.59%
- Debt to equity
- 0.66
Trading
- Volume
- 2,700
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 17,380,000
- Stochastic %K
- —
- Beta
- 469.33
- Analysts
- —
- Price target
- —
Company profile
On June 18, 2024, The Greenrose Holding Company Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of New York. The company, through its subsidiaries, previously engaged in the production and sale of cannabis products. It engaged in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is...
Show more
On June 18, 2024, The Greenrose Holding Company Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of New York. The company, through its subsidiaries, previously engaged in the production and sale of cannabis products. It engaged in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 516 346 6270
- Website
- https://www.greenroseholdings.com
- Address
- 111 Broadway, Amityville, United States
Latest news
No headlines yet.
